U.S. House Speaker Touts Benefits Of CBD And Industrial Hemp

The top Republican in the U.S. House has issued a surprise endorsement of a key marijuana ingredient’s medical benefits, as well as the uses of industrial hemp.

“It has proven to work,” Republican House Speaker Paul Ryan said of cannabidiol (CBD) on Oct. 30, 2018, specifying that it “helps reduce seizures.”

“We do this in Wisconsin,” he said, referring to his home state’s limited CBD law. “That that oil, I think works well.”

The speaker, who is not running for re-election and is retiring from Congress early next year, shared that his own mother-in-law used a synthetic form of cannabinoids, presumably the tetrahydrocannabinol (THC) pill Marinol, while dying from melanoma and ovarian cancer.

“That’s off the record,” he said jokingly, referencing TV cameras at the well-attended Kentucky rally where he was appearing in support of Republican Rep. Andy Barr, who is locked in a tight re-election race.

Ryan, responding to a medical marijuana question from a woman whose husband died, also proactively took the opportunity to speak up in support of industrial hemp.

“And by the way, there’s a lot of industrial uses for hemp that I understand from talking to Mitch McConnell is a big deal to Kentucky agriculture,” he said. “And we’re all in favor of that as well.”

Ryan’s endorsement for hemp comes at a key time. Congressional leaders are currently negotiating differences in the House and Senate versions of the Farm Bill. The Senate proposal contains language championed by McConnell, the GOP majority leader, that would legalize hemp. The House bill has no such provisions.

If the top Republican in either chamber is now vocally in support of ending the prohibition on marijuana’s non-intoxicating cousin, it seems more and more likely that the House will accept the Senate’s hemp language.

That said, don’t count the outgoing speaker as a die-hard marijuana supporter, even when it comes to medical uses.

“There’s no THC in that oil,” he said, even though most CBD preparations do have small amounts of the intoxicating cannabis compound. “That is not medical marijuana.”

In response to the medical marijuana question, Ryan also touted passage this year of the Right to Try Act — which appears to allow certain seriously ill people to use marijuana and other currently illegal drugs such as psilocybin, or “magic mushrooms,” and MDMA, popularly called ecstasy, though he did not mention those implications directly.

This article has been republished from Marijuana Moment under a content syndication agreement. Read the original article here.

Original Article Source: https://www.marijuana.com/news/2018/10/u-s-house-speaker-touts-benefits-of-cbd-and-industrial-hemp/

Comments

New York City Adds More Exceptions To Pre-Employment Marijuana Testing Ban

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the subs...

Virginia CBD Program Criticized As Multistate Medical Cannabis Operators Gain Edge

Seven companies are challenging a CBD licensing process in Virginia that resulted in multistate medical marijuana operators getting a majority of available licenses. The appeals called the process “wildly prejudicial.” Out of 51 applicants for five vertically integrated CBD and THC-A licenses, multistate operators received three, a situation that spurred the appeals, The Virginian-Pilot reported. Applicants filing the appeals complained the closed-meeting review process lacked fairness and transparency. One consultant to an applicant said the selections felt “predetermined.” The Virginia Board of Pharmacy reportedly sent information to the applicants in December explaining its selections, but some applicants weren’t satisfied. A board spokeswoman wrote in an email to the Pilot that the board “does not comment on pending litigation.” The five winning applicants , called “pharmaceutical processors,” have a year from winning the licenses to become operational. The multist...

Mississippi Medical Marijuana Activists Relieved After Controversial Legalization Resolution Stalls Out

Only a day after a new marijuana decriminalization law took effect in Virginia, top state lawmakers are announcing that they’re already looking ahead to full legalization. A group of Democratic legislators on Thursday announced plans to introduce a bill to legalize and regulate a commercial cannabis market in the state. While the measure isn’t set to be filed until next year, lawmakers framed legalization as necessary in the fight for social and racial justice. “Decriminalizing marijuana is an important step in mitigating racial disparities in the criminal justice system, but there is still much work to do,” House Majority Leader Charniele Herring (D) said in a press release. “While marijuana arrests across the nation have decreased, arrests in Virginia have increased.” Other lawmakers backing the broader legalization push include Sens. Adam Ebbin (D) and Jennifer McClellan (D), as well as Del. Steve Heretick (D). On Wednesday, the state’s new marijuana decriminalization policy t...

Susan Duggan

Search This Blog